The tale of two pandemics: Understanding racial and ethnic disparities from the collision of HIV and COVID-19 in the U.S.
两种流行病的故事:从美国 HIV 和 COVID-19 的碰撞中了解种族和民族差异
基本信息
- 批准号:10662546
- 负责人:
- 金额:$ 1.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-08 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAffectAmericanAreaBiological FactorsBlack PopulationsBlack raceCOVID-19COVID-19 impactCOVID-19 pandemicCOVID-19 pandemic effectsCaringCessation of lifeCharacteristicsClinicalColorCommunitiesDataData ScienceData SetDisparityEconomicsElectronic Health RecordEpidemicEquityEthnic OriginFrequenciesGoalsHIVHIV InfectionsHIV diagnosisHealth systemHospitalizationHousingImmune System DiseasesIncidenceIndividualInterruptionInterventionLaboratory MarkersLatinxLatinx populationMachine LearningMeasuresMediatingMediationMethodsModelingOutcomePathway interactionsPatientsPersonsPoliticsPopulationPopulation Attributable RisksPositioning AttributePreventionPrevention approachPublic HealthRaceRacial EquityRecording of previous eventsResearchRiskSARS-CoV-2 infectionSexually Transmitted DiseasesStructural RacismTestingUnited States National Institutes of HealthVaccinationViralbreakthrough infectioncohortcomorbiditycoronavirus diseasecurrent pandemicethnic disparityethnic minorityfuture pandemichealth disparityhealth equityhigh riskimplementation strategyimprovedinsightlearning strategyminority communitiesmultilevel analysisnext generationpandemic diseasepost-COVID-19pre-exposure prophylaxispredictive modelingpublic health interventionracial disparityracial minorityrepositoryresponsesevere COVID-19socialsocial determinantssocial factorssocial health determinantssocial interventionssocial vulnerabilitystatistical learningtransmission processvaccine effectiveness
项目摘要
PROJECT SUMMARY
The collision of the COVID-19 pandemic with the existing HIV epidemic in the U.S. has exacerbated the decades
old racial/ethnic disparities in HIV. For example, Blacks account for 42-44% of HIV diagnoses and deaths among
people living with HIV (PLWH) while accounting for only 12% of the population. These racialized disparities in
the U.S. HIV epidemic are further compounded by the same disparities emerging in COVID-19. We have shown
that PLWH appear to be at higher risk of poorer COVID-19 outcomes than persons not living with HIV (PNLWH),
and that the odds of incident COVID-19 infection among PLWH are 60% and 118% higher among Black and
Latinx persons, respectively, than whites. These racialized disparities are likely largely driven by social
determinants of health (SDoH) underlying our health systems—an understanding of the SDoH pathways that
elucidate these disparities is urgently needed to develop the next generation of HIV interventions operating at
the structural and social levels, and ever more now in the context of COVID-19.
The National COVID Cohort Collaborative (N3C) leverages real-world, national data and presents an
unprecedented opportunity to inform the NIH priority aims to understand the social and biologic factors that may
affect both HIV and COVID-19 outcomes. N3C is the largest electronic health record (EHR) repository in U.S.
history (>10M patients), contains both unparalleled individual-level granular clinical and historical data, and
represents the largest U.S. cohort of PLWH with their HIV and COVID-19 outcomes data (>77K), allowing
us to evaluate the bi-directional impact of existing HIV infection and COVID-19 outcomes. Furthermore,
individual-level data in the N3C are uniquely positioned to merge publicly available datasets that measure area-
level SDoH. Our central hypothesis is that the observed racial/ethnic disparities in HIV and COVID-19 occur in
a larger context of individuals embedded in social, political, and economic contexts, i.e., SDoH. Understanding
these forces, centered on SDoH, allows us to determine the next generation of HIV interventions.
Our three aims respond to the NIH call using data science, rigorous machine and statistical learning, and
multi-level mediation and epidemic modeling. The goal of Aim 1 (HIV outcomes) is to identify multilevel, social
determinants of racial/ethnic disparities in HIV outcomes (e.g., viral suppression [VS] and hospitalization) during
the COVID-19 pandemic. The goal of Aim 2 (COVID outcomes) is to understand the independent and
aggregated impact of SDoH and clinical characteristics on HIV immune dysfunction for COVID-19 outcomes and
vaccine effectiveness (2a) and quantify the differential impact of HIV on COVID-19 outcomes at the U.S.
population level by race/ethnicity (2b). The goal of Aim 3 (HIV epidemic modeling) is to quantify the impact of
the COVID-19 pandemic on HIV treatment (VS and hospitalization) and prevention (pre-exposure prophylaxis
[PrEP] use and HIV/sexually transmitted infections [STI] testing frequency) outcomes by race/ethnicity at the
population-level for the national Ending the HIV Epidemic (EHE) initiative’s priority jurisdictions.
项目摘要
联盟19日大流行与美国现有的艾滋病毒流行的碰撞加剧了数十年
艾滋病毒中的古老种族/种族差异。例如,黑人占HIV诊断和死亡的42-44%
患有艾滋病毒(PLWH)的人只占人口的12%。这些种族化的分布
美国艾滋病毒的流行进一步加剧了19日在Covid-19中出现的相同差异。我们已经显示了
与不忍受艾滋病毒(PNLWH)的人相比
在PLWH中发生Covid-19的事件的几率在黑色和
拉丁人分别比白人。这些种族化的分布可能在很大程度上是由社会驱动的
确定我们的卫生系统基础的健康(SDOH) - 对SDOH途径的理解
迫切需要阐明这些分布来发展下一代的HIV干预措施
结构和社会层面,现在在Covid-19的背景下更多。
国家共同队列合作(N3C)利用现实世界,国家数据并呈现
前所未有的机会通知NIH优先事项的旨在了解可能的社会和生物学因素
影响HIV和COVID-19的结果。 N3C是美国最大的电子健康记录(EHR)存储库
病史(> 10m患者)包含无与伦比的个体颗粒临床和历史数据,以及
代表最大的美国PLWH队列,其HIV和COVID-19结果数据(> 77K),允许
美国评估现有的HIV感染和COVID-19结果的双向影响。此外,
N3C中的个人级别数据是唯一的定位,可以合并公开可用的数据集,以衡量区域 -
级别SDOH。我们的中心假设是,艾滋病毒和互联19中观察到的种族/种族差异发生在
嵌入社会,政治和经济环境中的个人的更大背景,即SDOH。理解
这些以SDOH为中心的力使我们能够确定下一代HIV干预措施。
我们的三个目标使用数据科学,严格的机器和统计学习以及
多级调解和流行建模。目标1(艾滋病毒结果)的目标是确定多级,社会
艾滋病毒结局中种族/种族差异的决定因素(例如,病毒抑制[VS和住院)
19009年大流行。 AIM 2的目标(共同结果)是了解独立和
SDOH和临床特征对COVID-19结果的HIV免疫功能障碍的综合影响和
疫苗有效性(2A),并量化HIV对美国共同结果的差异影响
种族/种族的人口水平(2b)。目标3(HIV流行建模)的目的是量化
艾滋病毒治疗(VS和住院)和预防(暴露前预防
[PREP]使用和HIV/性传播感染[STI测试频率)
国家终止艾滋病毒流行(EHE)倡议的优先管辖权的人口级别。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rena Chiman Patel其他文献
Rena Chiman Patel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rena Chiman Patel', 18)}}的其他基金
The tale of two pandemics: Understanding racial and ethnic disparities from the collision of HIV and COVID-19 in the U.S.
两种流行病的故事:从美国 HIV 和 COVID-19 的碰撞中了解种族和民族差异
- 批准号:
10982807 - 财政年份:2022
- 资助金额:
$ 1.13万 - 项目类别:
The tale of two pandemics: Understanding racial and ethnic disparities from the collision of HIV and COVID-19 in the U.S.
两种流行病的故事:从美国 HIV 和 COVID-19 的碰撞中了解种族和民族差异
- 批准号:
10547314 - 财政年份:2022
- 资助金额:
$ 1.13万 - 项目类别:
Co-benefits of co-delivery of long-acting antiretrovirals and contraceptives
长效抗逆转录病毒药物和避孕药联合给药的协同效益
- 批准号:
10393063 - 财政年份:2021
- 资助金额:
$ 1.13万 - 项目类别:
Co-benefits of co-delivery of long-acting antiretrovirals and contraceptives
长效抗逆转录病毒药物和避孕药联合给药的协同效益
- 批准号:
10253981 - 财政年份:2021
- 资助金额:
$ 1.13万 - 项目类别:
Co-benefits of co-delivery of long-acting antiretrovirals and contraceptives
长效抗逆转录病毒药物和避孕药联合给药的协同效益
- 批准号:
10609537 - 财政年份:2021
- 资助金额:
$ 1.13万 - 项目类别:
Using systems science to optimize the impact of point-of-care viral load testing for pediatric HIV management
利用系统科学优化床旁病毒载量检测对儿科艾滋病毒管理的影响
- 批准号:
10263333 - 财政年份:2020
- 资助金额:
$ 1.13万 - 项目类别:
Investigating interactions between efavirenz-based antiretroviral therapy and contraceptive implants
研究基于依非韦伦的抗逆转录病毒疗法与植入式避孕药之间的相互作用
- 批准号:
9088349 - 财政年份:2015
- 资助金额:
$ 1.13万 - 项目类别:
Investigating interactions between efavirenz-based antiretroviral therapy and contraceptive implants
研究基于依非韦伦的抗逆转录病毒疗法与植入式避孕药之间的相互作用
- 批准号:
9178400 - 财政年份:2015
- 资助金额:
$ 1.13万 - 项目类别:
Investigating interactions between efavirenz-based antiretroviral therapy and contraceptive implants
研究基于依非韦伦的抗逆转录病毒疗法与植入式避孕药之间的相互作用
- 批准号:
8993281 - 财政年份:2015
- 资助金额:
$ 1.13万 - 项目类别:
相似国自然基金
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
儿童期受虐经历影响成年人群幸福感:行为、神经机制与干预研究
- 批准号:32371121
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:32200888
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
生活方式及遗传背景对成人不同生命阶段寿命及死亡的影响及机制的队列研究
- 批准号:82173590
- 批准年份:2021
- 资助金额:56.00 万元
- 项目类别:面上项目
相似海外基金
Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
- 批准号:
10676358 - 财政年份:2024
- 资助金额:
$ 1.13万 - 项目类别:
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:
10822202 - 财政年份:2024
- 资助金额:
$ 1.13万 - 项目类别:
A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
- 批准号:
10752276 - 财政年份:2024
- 资助金额:
$ 1.13万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 1.13万 - 项目类别:
Iron deficits and their relationship with symptoms and cognition in Psychotic Spectrum Disorders
铁缺乏及其与精神病谱系障碍症状和认知的关系
- 批准号:
10595270 - 财政年份:2023
- 资助金额:
$ 1.13万 - 项目类别: